Webinar: Pharma Goes Digital – Know the Economic Impact

New Model Results are In - See the Numbers

When: April 21, 2022
Where: Virtual Event

The data is in, and savvy pharma execs see that supporting patient engagement is not only a growing strategic initiative for pharma companies but is proving to be an impactful value driver.

Now pharma organizations know what their investment could generate in terms of financial benefits and clinical outcomes.

This webinar covers:
– The five major impacts that digital drug companions deliver for pharma;
– The real-world evidence and sources that validate the numbers;
– How competitors and execs are already valuing the digital drug companion market

You may also like

Enhancing Multiple Sclerosis Patient Outcomes Through Digital Engagement

Multiple Sclerosis (MS) represents a formidable challenge in healthcare, a chronic, often unpredictable disease of the central nervous system that 

..Read More

Boosting Diabetes Adherence: Medisafe Digital Tools Deliver Results

Summary Managing diabetes presents significant challenges both for patients and pharmaceutical companies. Adherence to medication regimens, continuous monitoring, and lifestyle 

..Read More

High-Stakes GLP-1s: Where Digital Reinforcement Becomes Mission-Critical

Today’s groundbreaking announcement from Novo Nordisk and Eli Lilly to reduce the cost of their blockbuster weight loss drugs in 

..Read More

Want to Learn More?

We bring decades of experience to your challenges—and technology and solutions uniquely designed to meet your needs.